| Metric | შპს SmartPharm | შპს ფარმაცევტული სახლი + | შპს იმპექსფარმი | შპს იბერიფარმა + |
|---|---|---|---|---|
| Growth | ||||
| Revenue | ₾32.2m₾23.8m | ₾54.7m₾40.3m | ₾108.9m₾93.3m | ₾7.2m₾7.1m |
| Revenue growth | 35.4% | 35.6% | 16.7% | 2.2% |
| Profitability | ||||
| EBITDA | ₾2.9m₾2.7m | -₾3.2m | ||
| ₾7.7m₾6.6m |
| -₾778k-₾152k |
| EBITDA margin | 9.1%11.4% | -5.9%-2.3% | 7.1%7.1% | -10.7%-2.1% |
| Net profit | ₾2.6m₾2.4m | -₾1.6m-₾3.3m | ₾9.1m₾6.7m | -₾778k-₾152k |
| Net margin | 8.0%10.2% | -3.0%-8.2% | 8.3%7.2% | -10.7%-2.1% |
| Balance sheet | ||||
| Total assets | ₾10.8m₾8.5m | ₾38.3m₾34.8m | ₾83.9m₾72.7m | ₾1.6m₾1.8m |
| Total equity | ₾7.2m₾4.9m | -₾2.9m-₾1.3m | ₾58.6m₾50.1m | -₾1.1m-₾344k |
| ROE | 35.6%49.1% | — | 15.5%13.4% | — |